Mizuho Medy Co Ltd
TSE:4595

Watchlist Manager
Mizuho Medy Co Ltd Logo
Mizuho Medy Co Ltd
TSE:4595
Watchlist
Price: 2 289 JPY -0.82% Market Closed
Market Cap: 34.4B JPY

Mizuho Medy Co Ltd
Pre-Tax Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Mizuho Medy Co Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Mizuho Medy Co Ltd
TSE:4595
Pre-Tax Income
ÂĄ4.5B
CAGR 3-Years
-18%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Terumo Corp
TSE:4543
Pre-Tax Income
ÂĄ170.6B
CAGR 3-Years
18%
CAGR 5-Years
14%
CAGR 10-Years
9%
Olympus Corp
TSE:7733
Pre-Tax Income
ÂĄ149.6B
CAGR 3-Years
-2%
CAGR 5-Years
15%
CAGR 10-Years
29%
Sysmex Corp
TSE:6869
Pre-Tax Income
ÂĄ70.9B
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
3%
Nihon Kohden Corp
TSE:6849
Pre-Tax Income
ÂĄ20.4B
CAGR 3-Years
-15%
CAGR 5-Years
5%
CAGR 10-Years
2%
JEOL Ltd
TSE:6951
Pre-Tax Income
ÂĄ26.8B
CAGR 3-Years
11%
CAGR 5-Years
23%
CAGR 10-Years
16%
No Stocks Found

Mizuho Medy Co Ltd
Glance View

Market Cap
34.4B JPY
Industry
Health Care

Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

Intrinsic Value
1 970.73 JPY
Overvaluation 14%
Intrinsic Value
Price

See Also

What is Mizuho Medy Co Ltd's Pre-Tax Income?
Pre-Tax Income
4.5B JPY

Based on the financial report for Jun 30, 2025, Mizuho Medy Co Ltd's Pre-Tax Income amounts to 4.5B JPY.

What is Mizuho Medy Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
49%

Over the last year, the Pre-Tax Income growth was -16%. The average annual Pre-Tax Income growth rates for Mizuho Medy Co Ltd have been -18% over the past three years , 49% over the past five years .

Back to Top